Search

Author/Creator Hsu, Chyi‐Hung

1. Dynamic population pharmacokinetic–pharmacodynamic modelling and simulation supports similar efficacy in glycosylated haemoglobin response with once or twice‐daily dosing of canagliflozin. (31st January 2017)

Authors:
de Winter, Willem; Dunne, Adrian; de Trixhe, Xavier Woot; Devineni, Damayanthi; Hsu, Chyi‐Hung; Pinheiro, Jose; Polidori, David
Journal:
British journal of clinical pharmacology
Issue:
Volume 83:Number 5(2017:May)
Page Start:
1072
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Translational PK/PD and model‐informed development of JNJ‐67842125, a Fab reversal agent for JNJ‐64179375, a long‐acting thrombin inhibitor. (29th June 2021)

Authors:
Ayyar, Vivaswath S.; Jaiprasart, Pharavee; Geist, Brian; Huang Devine, Zheng; Case, Martin; Hazra, Anasuya; Hsu, Chyi‐Hung; Chintala, Madhu; Wang, Weirong
Journal:
British journal of pharmacology
Issue:
Volume 178:Number 19(2021)
Page Start:
3943
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗